Sputnik V

Beneficiaries in Bhubaneswar belonging to both age groups (18-44 years and above 45 years) can book their slots on CoWIN portal to get Sputnik V Vaccine from tomorrow.

On April 12th 2021, the Subject Expert Committee (SEC), a top advisory committee linked to the Drug Controller General of India, authorized Sputnik V, a COVID-19 vaccine created by the Moscow-based Gamaleya Institute, for emergency use.

Sputnik V, a Russian-made COVID vaccine will be the third vaccine to be used after Covishield and Covaxin in India. Russian Covid Vaccine

While COVID-19 cases continue to explode in India with the peak stage of community transmission is underway, there is a ray of hope from Russia. The Russian Direct Investment Fund expects to start supplying COVID-19 Vaccine Sputnik V to…

TNI Bureau: Russia has finally begun rolling out of its COVID-19 vaccine - Sputnik V. The developers are planning to conduct large-scale clinical trials while administering the shot to public. There will be a year-long mass vaccination…